Lonza’s softgel interests wane with sale of two European sites 21-Jan-2021 By Will Chu Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets.